Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest UNC Lineberger Comprehensive Cancer Center Stories

2013-07-02 20:21:12

HACKENSACK, N.J., July 2, 2013 /PRNewswire-USNewswire/ -- John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, presented Governor Chris Christie with the 2013 Leadership Award during a ceremony Tuesday, July 2 honoring the Governor for his contributions in the prevention and treatment of cancer. (Photo: http://photos.prnewswire.com/prnh/20130702/DC42334) "Increasing access to high-quality cancer treatment services for New...

2013-06-26 10:16:52

Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it's the most common lymphoma subtype while in dogs, it's one of the most common cancers in veterinary oncology. A team of scientists from the University of North Carolina School of Medicine, North Carolina State University's College of Veterinary Medicine and Duke University have conducted one of the first studies to directly compare canine and human B-cell...

2013-06-03 23:03:07

Poster presented at the 2013 Annual Meeting of the American Society of Clinical Oncology shows patients want and seek information but are not offered it Chicago, IL (PRWEB) June 03, 2013 The Cancer Support Community (CSC) released data today showing a significant gap in patient desire to have conversations about the cost of cancer care and initiation of conversations by the health care team. In a study of 708 people attending CSC´s Frankly Speaking About Cancer: Coping with the Cost...

Biological Diversity In Triple-negative Breast Cancer Discovered By Researchers
2013-02-14 12:25:02

University of North Carolina Health Care Triple-negative breast cancers are more biologically diverse than previously believed and classification should be expanded to reflect this heterogeneity, according to University of North Carolina researchers. In a study published in the February issue of The Oncologist conducted by UNC and the Vall d'Hebron Institute of Oncology in Barcelona, Spain, a team lead by Charles Perou, PhD, of UNC Lineberger Comprehensive Cancer Center, examined more...

2013-02-13 17:51:08

In a paper published by Cell Host and Microbe on Feb. 13, a research team led by Blossom Damania, PhD, of the Department of Microbiology and Immunology and member of the UNC Lineberger Comprehensive Cancer Center, found that suppressing the TLK enzyme causes the activation of the lytic cycle of both EBV and KSHV. During this active phase, these viruses begin to spread and replicate, and become vulnerable to anti-viral treatments. “When TLK is present, these viruses stay latent, but...

2013-01-21 12:23:28

First of its kind clinic will screen children who are most susceptible to childhood cancers HOUSTON, Jan. 21, 2013 /PRNewswire-USNewswire/ -- Texas Children's Cancer Center announced a new, first of its kind, Childhood Cancer Prevention and Screening Clinic which will screen and follow children who are at an elevated risk for developing childhood cancer. This new clinic will reassure families of children with genetic conditions such as Li-Fraumeni syndrome and Beckwith-Wiedemann syndrome...

2012-12-29 05:00:59

Drs. William Y. Kim, of UNC, and James W. Mier, of Harvard, will each receive $250,000 grants to support innovative, translational kidney cancer research. Newport Beach, CA (PRWEB) December 28, 2012 The American Association for Cancer Research and Kure It are pleased to announce that William Y. Kim, M.D., and James W. Mier, M.D., will each receive a 2012 AACR-Kure It Grant for Kidney Cancer Research. Kim, assistant professor in the departments of medicine and genetics at the University of...

2012-10-04 06:26:07

Symbolizes Launch of Full Implementation of Novel, Distributed Approach to Cancer Care CHARLOTTE, N.C., Oct. 4, 2012 /PRNewswire-USNewswire/ -- Carolinas HealthCare System's (CHS) Levine Cancer Institute announced the opening of its research and administrative headquarters on the campus of CHS's Carolinas Medical Center in Charlotte, N.C. By integrating and building upon CHS's network of elite cancer programs and centers, the Institute is able to provide its more than 11,000 new cancer...

2012-09-20 16:43:40

The cost of sequencing the entire human genome, or exome — the regions of the genome that are translated into proteins that affect cell behavior — has decreased significantly, to the point where the cost of looking at the majority of a patient's genomic data may be less expensive than undertaking one or two targeted genetic tests. While efficient, the acquisition of this much genetic data — in some cases as many as 1.5 to 2 million variants — creates other challenges....

2012-09-19 23:03:42

A new study published in The Oncologist found that genetically engineered mouse models appear to be the most accurate preclinical predictor of how cancer-fighting drugs are delivered to melanoma patients. The study, led by UNC-Chapel Hill researchers along with colleagues in the Research Triangle Park, Pittsburgh and Austria, tested how four different types of mouse models predict the delivery of carboplatin, a commonly used anticancer drug, to melanoma tumors in patients. Durham, NC (PRWEB)...